For children, older adults, patients with dysphagia, individuals with chronic diseases, and certain patients with neurological disorders, whether a medication is "easy to take" often directly affects treatment adherence, dosing accuracy, and long-term therapeutic outcomes.

With the continuous advancement of precision medicine and lifelong health management, modern drug development is no longer focused solely on efficacy and safety. Optimization of dosage forms has also become a critical factor in improving therapeutic outcomes. Beyond traditional tablets and capsules, innovative formulations—including oral solutions, orally disintegrating tablets (ODTs), transdermal patches, sustained-release formulations, and many others—are increasingly being developed to meet the individualized medication needs of different patient populations. Clinical practice has shown that selecting an appropriate dosage form not only improves the patient experience but may also reduce missed doses, minimize administration difficulties, and enhance long-term disease management.

Why Are Dosage Forms Especially Important for Special Populations?

For healthy adults, conventional tablets generally meet most therapeutic needs. However, for special populations, medication therapy is influenced not only by the drug itself but also by swallowing ability, physiological characteristics, cognitive function, gastrointestinal absorption, and lifestyle factors.

For example, children's swallowing function is not yet fully developed, while older adults may experience dysphagia due to reduced muscle strength, neurological disorders, or oral diseases. Patients with chronic illnesses often require lifelong medication, and complicated dosing regimens may reduce adherence. In addition, conditions such as nausea, vomiting, and impaired gastrointestinal function may affect the absorption of orally administered drugs.

As a result, modern pharmaceutics increasingly emphasizes a patient-centered approach, designing dosage forms that better suit individual patient characteristics while improving convenience and safety without compromising therapeutic efficacy.

Oral Solutions: Better Suited for Children and Patients with Swallowing Difficulties

Oral solutions are among the most widely used liquid dosage forms in clinical practice. Their greatest advantage is that patients do not need to swallow an intact solid dosage form, making them particularly suitable for children, older adults, and individuals with impaired swallowing function.

Compared with conventional tablets, liquid formulations generally have a faster onset of action because the drug does not need to undergo a disintegration process before absorption. In addition, oral solutions allow flexible dose adjustment based on body weight, age, or specific clinical conditions, making them especially suitable for precision dosing in pediatric patients.

However, oral solutions also have certain limitations. Some medications have limited stability and require refrigerated storage. Certain formulations contain sugars, sweeteners, or preservatives and should therefore be used cautiously in patients with diabetes or those with specific sensitivities. Furthermore, liquid medications require accurate measurement using a dosing cup or oral syringe to minimize dosing errors.

Therefore, when using oral solutions, patients should carefully measure each dose according to the prescribing information or healthcare provider's instructions and should never substitute household spoons for calibrated dosing devices.

Orally Disintegrating Tablets (ODTs): Improved Convenience Without Water

Orally Disintegrating Tablets (ODTs) are one of the fastest-growing innovative oral dosage forms in recent years. They rapidly disintegrate in the mouth, allowing patients to take the medication without the need for a large amount of water.

This dosage form is particularly suitable for:

● Children and adolescents;

● Older adults;

● Patients with swallowing difficulties;

● Patients experiencing nausea or vomiting;

● Individuals who are traveling or unable to access drinking water.

Although ODTs dissolve quickly in the oral cavity, most drugs are still primarily absorbed through the gastrointestinal tract. Therefore, their principal advantage is not improved bioavailability, but rather enhanced convenience and better treatment adherence.

It should also be noted that ODTs are generally highly moisture-sensitive. They should not be exposed to air for prolonged periods and should be stored according to the manufacturer's packaging instructions to maintain stability.

Transdermal Patches: Continuous and Stable Drug Delivery

Transdermal patches deliver medication continuously through the skin into the systemic circulation and have become one of the most important dosage forms in chronic disease management.

Compared with multiple daily oral doses, transdermal patches help maintain more consistent plasma drug concentrations, reducing fluctuations that may affect therapeutic efficacy while lowering the risk of missed doses.

In addition, transdermal administration bypasses gastrointestinal absorption and first-pass metabolism, making it advantageous for patients with impaired gastrointestinal function or those unable to take oral medications.

However, transdermal patches are not suitable for every drug. Medications intended for transdermal delivery must possess appropriate molecular weight, lipophilicity, and dosage characteristics. Consequently, they are currently used primarily in pain management, neurological disorders, hormone replacement therapy, and certain chronic diseases.

When using transdermal patches, patients should rotate application sites to avoid prolonged local skin irritation and replace patches according to the recommended schedule to maintain consistent therapeutic effects.

Sustained-Release and Controlled-Release Formulations: Improving Long-Term Treatment Adherence

For patients requiring long-term medication, the importance of sustained-release (SR) and controlled-release (CR) formulations continues to grow.

These dosage forms utilize specialized pharmaceutical technologies that gradually release the drug over time, thereby prolonging therapeutic effects and reducing dosing frequency.

Compared with conventional formulations, their primary advantages include:

● Reduced dosing frequency, improving long-term treatment adherence;

● More stable plasma drug concentrations;

● Reduced peak-to-trough fluctuations in drug levels;

● Lower risk of certain drug-related adverse effects.

However, these formulations rely on carefully designed release mechanisms and therefore should not be split, crushed, or chewed unless specifically instructed. Doing so may cause rapid drug release, reduce therapeutic effectiveness, or increase the risk of adverse reactions.

Patients should therefore carefully read the prescribing information and follow the advice of their physician or pharmacist before using sustained-release or controlled-release medications.

How Do Specialized Dosage Forms Enable Truly Personalized Medication?

Modern pharmacotherapy increasingly emphasizes individualized treatment, and dosage-form selection has become an essential part of this process.

When developing treatment plans, clinicians evaluate not only the disease and drug mechanism of action but also factors such as patient age, swallowing ability, cognitive status, liver and kidney function, lifestyle, and long-term medication requirements. For example, simplifying medication regimens often improves adherence among patients with chronic diseases, while dosage forms that avoid swallowing or bypass the gastrointestinal tract may be preferable for patients with dysphagia or impaired gastrointestinal function.

Meanwhile, innovative drug delivery technologies continue to evolve. Emerging dosage forms—including microneedle patches, long-acting injectable formulations, nasal sprays, implantable drug delivery systems, and smart controlled-release technologies—are gradually entering clinical research and practice. These innovations not only improve the patient experience but also create new opportunities for precision dosing, long-term disease management, and improved therapeutic outcomes.

Conclusion

As pharmaceutical research continues to advance, dosage-form innovation has become an increasingly important direction in modern medicine. From oral solutions and orally disintegrating tablets to transdermal patches and sustained-release formulations, these diverse dosage forms reflect not only advances in pharmaceutical technology but also the growing emphasis on patient-centered healthcare. In the future, specialized dosage forms are expected to play an even greater role in the treatment of children, older adults, patients with chronic diseases, and individuals with rare diseases by improving medication adherence and optimizing long-term disease management.

At the same time, although an increasing number of innovative formulations are being introduced worldwide, differences in drug accessibility still exist across countries and regions. As a professional platform dedicated to global innovative medicines, specialized dosage forms, and international pharmaceutical services, DengYueMed continuously monitors international advances in pharmaceutical formulation technologies, novel drug delivery systems, and global drug development trends. The platform provides professional pharmaceutical information, international drug intelligence, drug source verification, and consultation on compliant access channels for patients, healthcare institutions, and industry partners.